Circulating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive CancersApril 12, 2024Patient & Survivor CareBreast CancerGastrointestinal CancerCNS/Brain CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid Cancers
Repeat MCED Testing May ID Early-Stage and Unscreened CancersApril 10, 2024Preventive CareBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersGastrointestinal Cancer
ImPrint Identifies Patients With Breast Cancer Likely to Respond to Neoadjuvant ImmunotherapyApril 10, 2024Breast CancerMetastatic Breast CancerPatient & Survivor Care
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
FDA Expands Enhertu Indication to HER2-Positive Solid TumorsApril 9, 2024Breast CancerPatient & Survivor CarePractice ManagementGastrointestinal CancerMetastatic Breast Cancer
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024Patient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Patient & Survivor CareOpioid Resource CenterPreventive CareBreast CancerCNS/Brain CancerFollicular LymphomaGastroenterology
A Banned Chemical That Is Still Causing CancerApril 3, 2024Preventive CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Practice ManagementGastrointestinal CancerGenitourinary CancerBreast CancerMetastatic Breast CancerCNS/Brain CancerFollicular Lymphoma
New Guidance for the Treatment of Metastatic Breast CancerMarch 26, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CarePractice Management
Few Childhood Cancer Survivors Get Recommended ScreeningsMarch 25, 2024PediatricsPatient & Survivor CarePreventive CareDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Most Cancer Trial Centers Located Closer to White, Affluent PopulationsMarch 21, 2024Practice ManagementBreast CancerPatient & Survivor CareRenal Cell CarcinomaSarcoma & GISTNonmelanoma Skin CancerNeuro-oncology
New Drug Approvals Are the Wrong Metric for Cancer PolicyMarch 20, 2024Practice ManagementMixed TopicsBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Extraordinary Patients Inspired Father of Cancer ImmunotherapyMarch 19, 2024ImmunotherapyPractice ManagementMixed TopicsMetastatic Breast CancerMelanomaSarcoma & GISTRenal Cell Carcinoma
Combining Targeted Drugs and Radiation in Breast Cancer: What’s Safe?March 18, 2024Breast CancerPatient & Survivor CareMixed TopicsMetastatic Breast Cancer
